Proniosomes as a novel drug carrier system for buccal delivery of benzocaine

Journal of Drug Delivery Science and Technology

Volumn 24, Issue 5, 2014, Pages 452-458

  Abd El Alim, S H ^a   Kassem, A A ^a   Basha, M ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Benzocaine; Drug release; Local anesthetics; Mucosal pain; Proniosomes; Vesicular systems

Indexed keywords

BENZOCAINE; DRUG CARRIER; NIOSOME; PRONIOSOME; SORBITAN OLEATE; SORBITAN STEARATE; SORBITAN TRIOLEATE; SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHEEK MUCOSA; CHEEK POUCH; CHICKEN; COACERVATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG RETENTION; DRUG STABILITY; DRUG STORAGE; ENCAPSULATION; EX VIVO STUDY; FEASIBILITY STUDY; HYDROPHOBICITY; IN VITRO STUDY; LIPOPHILICITY; LIPOSOME MEMBRANE; MOUTH CAVITY; MUCOSA; NONHUMAN; PARTICLE SIZE; PHASE SEPARATION; SOLUBILITY; TRANSITION TEMPERATURE; ZETA POTENTIAL;

EID: 84908372867     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(14)50087-1     Document Type: Article

References (60)

1. Sonis S.T., Etting L.S., Keefe D., Peterson D.E., Schubert M., Hauer-Jensen M., Bekele B.N., Raber-Durlacher J., Donnelly J.P., Rubenstein E.B.-Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.-Cancer, 100 (9 Suppl), 1995-2025, 2004.
2. Rodriguez-Caballero A., Torres-Lagares D., Robles-Garcia M., Pachon-lbanez J., Gonzalez-Padilla D., Gutierrez-Perez J.L.-Cancer treatment-induced oral mucositis: a critical review.-Int J Oral Maxillofac Surg, 41(2), 225-238, 2012.
3. Au J., Patel D., Campbell J.H.-Oral lichen planus.-Oral Maxillofac Surg Clin North Am, 25(1), 93-100, vii, 2013.
4. Scully C., Felix D.H.-Oral medicine-update for the dental practitioner. Aphthous and other common ulcers.-Br Dent J, 199(5), 259-264, 2005.
5. Nicolatou-Galitis O., Nikolaidi A., Athanassiadis I., Papadopou-lou E., Sonis S.-Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management.-Oral Surg Oral Med Oral Pathol Oral Radiol, 116(2), e110-116,2013.
6. Ni Riordain R., Meaney S., McCreary C.-A patient-centered approach to developing a quality-of-lif e questionnaire for chronic oral mucosal diseases.-Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 111(5), 578-586, 586 e571-572, 2011.
7. Hearnden V., Sankar V., Hull K., Juras D.V., Greenberg M., Kerr A.R., Lockhart P.B., Patton L.L., Porter S., Thornhill M.H.-New developments and opportunities in oral mucosal drug delivery for local and systemic disease.-Adv Drug Deliv Rev, 64(1), 16-28,2012.
8. de Paula E., Schreier S., Jarrell H.C., Fraceto L.F.-Preferential location of lidocaine and etidocaine in lecithin bilayers as determined by EPR, fluorescence and 2H NMR.-Biophys. Chem., 132(1), 47-54, 2008.
9. Ogle O.E., Mahjoubi G.-Local anesthesia: agents, techniques, and complications.-Dent Clin North Am, 56(1), 133-148, ix, 2012.
10. Giovannitti J.A., Jr., Rosenberg M.B., Phero J.C.-Pharmacology of local anesthetics used in oral surgery.-Oral Maxillofac Surg Clin North Am, 25(3), 453-465, vi, 2013.
11. McLure H.A., Rubin A.P.-Review of local anaesthetic agents.-Minerva Anestesiol., 71(3), 59-74,2005.
12. Pinto L.M., Yokaichiya D.K., Fraceto LR, de Paula E.-Interaction of benzocaine with model membranes.-Biophys Chem, 87(2-3), 213-223, 2000.
13. Jaffery Z., Ananthasubramaniam K.-A rare side effect of transesophageal echocardiography: methemoglobinemia from topical benzocaine anesthesia.-Eur J Echocardiogr, 9(2), 289-290, 2008.
14. Butterworth J.F., Strichartz G.R.-Molecular mechanisms of local anesthesia: a review.-Anesthesiology, 72(4), 711-734, 1990.
15. Shahiwala A., Misra A.-Studies in topical application of nio-somally entrapped Nimesulide.-J. Pharm. Pharm. Sci., 5(3), 220-225, 2002.
16. Bochot A., Fattal E.-Liposomes for intravitreal drug delivery: a state of the art.-J. Control. Release, 161(2), 628-634,2012.
17. Mahale N.B., Thakkar P.D., Mali R.G., Walunj D.R., Chaud-hari S.R.-Niosomes: novel sustained release nonionic stable vesicular systems-an overview.-Adv. Colloid Interface Sci., 183-184,46-54, 2012.
18. Liu D., Hu H., Lin Z., Chen D., Zhu Y., Hou S., Shi X.-Quercetin deformable liposome: preparation and efficacy against ultraviolet B induced skin damages in vitro and in vivo.-J Photochem Photobiol B, 127,8-17,2013.
19. Kaur I.P., Garg A., Singla A.K., Aggarwal D.-Vesicular systems in ocular drug delivery: an overview.-Int. J. Pharm., 269(1), 1-14,2004.
20. Franz-Montan M., de Paula E., Groppo F.C., Silva A.L., Ranali J., Volpato M.C.-Liposome-encapsulated ropivacaine for intraoral topical anesthesia.-Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 110(6), 800-804,2010.
21. Muzzalupo R., Tavano L, Cassano R., Trombino S., Ferrarelli T., Picei N.-A new approach for the evaluation of niosomes as effective transdermal drug delivery systems.-Eur J Pharm Biopharm, 79(1), 28-35,2011.
22. Kong M., Park H., Feng C, Hou L, Cheng X., Chen X.-Construction of hyaluronic acid noisome as functional transdermal nanocarrier for tumor therapy.-Carbohydr Polym, 94(1), 634-641,2013.
23. Marianecci C, Di Marzio L, Rinaldi F., Celia C, Paolino D., Alhaique F., Esposito S., Carata M.-Niosomes from 80s to present: The state of the art.-Adv Colloid Interface Sci, 2013.
24. Pham T.T., Jaafar-Maalej C, Charcosset C, Fessi H.-Liposome and niosome preparation using a membrane contactor for scale-up.-Colloids Surf. B: Biointerfaces, 94,15-21,2012.
25. Hu C., Rhodes D.G.-Proniosomes: a novel drug carrier preparation.-Int. J. Pharm., 206(1-2), 110-122, 2000.
26. Vora B., Khopade A.J., Jain N.K.-Proniosome based transdermal delivery of levonorgestrel for effective contraception.-J. Control. Release, 54(2), 149-165,1998.
27. Fang J.Y., Yu S.Y, Wu P.C., Huang Y.B., Tsai YH.-In vitro skin permeation of estradiol from various proniosome formulations.-Int. J. Pharm., 215(1-2), 91-99,2001.
28. Varshosaz J., Pardakhty A., Baharanchi S.M.-Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate.-Drug Deliv., 12(2), 75-82,2005.
29. Abd-Elbary A., El-laithy H.M., Tadros M.I.-Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium.-Int. J. Pharm., 357(1-2), 189-198,2008.
30. El-Laithy H.M., Shoukry O., Mahran L.G.-Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies.-Eur. J. Pharm. Biopharm., 77(1), 43-55, 2011.
31. Perrett S., Golding M., Williams W.P.-A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes.-J. Pharm. Pharmacol., 43(3), 154-161, 1991.
32. Mokhtar M., Sammour O.A., Hammad M.A., Megrab N.A.-Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.-Int. J. Pharm., 361(1-2), 104-111,2008.
33. Kamel R., Basha M., Abd El-Alim S.H.-Development of a novel vesicular system using a binary mixture of sorbitan monostearate and polyethylene glycol fatty acid esters for rectal delivery of rutin.-J. Liposome Res., 23(1), 28-36,2013.
34. El-Ridy M.S., Abdelbary A., Essam T., El-Salam R.M., Kassem A.A.-Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin.-Drug Dev. Ind. Pharm., 37(12), 1491-1508, 2011.
35. Agarwal V., Mishra B.-Design, development, and biopharma-ceutical properties of buccoadhesive compacts of pentazocine.-Drug Dev. Ind. Pharm., 25(6), 701-709,1999.
36. Tayel S.A., Soliman, II, Louis D.-Formulation of ketotifen f umarate fast-melt granulation sublingual tablet.-AAPS Pharm-SciTech, 11(2), 679-685, 2010.
37. Bird A.P., Faltinek J.R., Shojaei A.H.-Transbuccal peptide delivery: stability and in vitro permeation studies on endomor-phin-1.-J. Control. Release, 73(1), 31-36,2001.
38. Ammar H.O., Ghorab M., El-Nahhas S.A., Higazy I.M.-Proniosomes as a carrier system for transdermal delivery of tenoxi-cam.-Int. J. Pharm., 405(1-2), 142-152,2011.
39. Pardakhty A., Varshosaz J., Rouholamini A.-In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.-Int. J. Pharm., 328(2), 130-141,2007.
40. Ibrahim M.M., Sammour O.A., Hammad M.A., Megrab N.A.-In v/froevaluation of proniosomes as a drug carrier for flurbiprofen.-AAPS PharmSciTech, 9(3), 782-790, 2008.
41. Aboelwafa A.A., El-Setouhy D.A., Elmeshad A.N.-Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal Carvedilol proniosomal gel using experimental design.-AAPS PharmSciTech, 11(4), 1591-1602,2010.
42. Mura P., Maestrelli F., Gonzalez-Rodriguez M.L., Michelacci I., Ghelardini C, Rabasco A.M.-Development, characterization and in vivo evaluation of benzocaine-loaded liposomes.-Eur. J. Pharm. Biopharm., 67(1), 86-95,2007.
43. de Paula E., Schreier S.-Use of a novel method for determination of partition coefficients to compare the effect of local anesthetics on membrane structure.-Biochim. Biophys. Acta, 1240(1), 25-33, 1995.
44. Cereda CM., de Araujo D.R., Brunetto G.B., De Paula E.-Liposomal prilocaine: preparation, characterization, and in vivo evaluation.-J. Pharm. Pharm. Sci., 7(2), 235-240,2004.
45. Marianecci C, Paolino D., Celia C, Fresta M., Carata M., Alhaique F.-Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts.-J. Control. Release, 147(1), 127-135, 2010.
46. Alsarra I.A., Bosela A.A., Ahmed S.M., Mahrous G.M.-Proniosomes as a drug carrier for transdermal delivery of ketorolac.-Eur. J. Pharm. Biopharm., 59(3), 485-490,2005.
47. Yoshioka T., Sternberg B., Florence A.T.-Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20,40,60 and 80) and a sorbitan triester (Span 85).-Int. J. Pharm., 105,1-6,1994.
48. Centis V., Vermette P.-Physico-chemical properties and cytotoxicity assessment of PEG-modified liposomes containing human hemoglobin.-Colloids Surf. B: Biointerfaces, 65(2), 239-246, 2008.
49. Sentjurc M., Vrhovnik K., Kristl J.-Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method.-J. Control. Release, 59(1), 87-97,1999.
50. Heurtault B., Saulnier P., Pech B., Proust J.E., Benoit J.P.-Physico-chemical stability of colloidal lipid particles.-Biomateri-als, 24(23), 4283-4300, 2003.
51. Manosroi A., Khanrin P., Lohcharoenkal W., Werner R.G., Götz F., Manosroi W., Manosroi J.-Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes.-Int J Pharm, 392(1-2), 304-310,2010.
52. JunyaprasertV.B., TeeranachaideekulV., SupapermT.-Effect of charged and non-ionic membrane additives on physicochemi-cal properties and stability of niosomes.-AAPS PharmSciTech, 9(3), 851-859,2008.
53. Dukhin A.S., Göetz P.J.-How non-ionic "electrically neutral" surfactants enhance electrical conductivity and ion stability in non-polar liquids.-J Electroanal Chem, 588(1), 44-50, 2006.
54. Morula M.J., Benavidez P., Lopez M.O., Bakas L, Romero E.L-Development and in vitro characterisation of a benznidazole liposomal formulation.-Int. J. Pharm., 249(1-2), 89-99, 2002.
55. Namdeo A., Jain N.K.-Niosomal delivery of 5-fluorouracil.-J. Microencapsul., 16(6), 731-740,1999.
56. Patel H.K., Barot B.S., Parejiya P.B., Shelat P.K., Shukla A.-Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo: ex vivo permeation and skin irritation studies.-Colloids Surf. B: Biointerfaces, 102, 86-94, 2013.
57. Gupta P.N., Mishra V, Rawat A., Dubey P., Mahor S., Jain S., Chatterji D.P., Vyas S.P.-Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study.-Int. J. Pharm., 293(1-2), 73-82, 2005.
58. Tamizharasi S., Dubey A., Rathi V., Rathi J.C.-Development and characterization of niosomal drug delivery of gliclazide.-J. Young Pharm., 1(3), 205-209,2009.
59. Balakrishnan P., Shanmugam S., Lee W.S., Lee W.M., Kim J.O., Oh D.H., Kim D.D., Kim J.S., Yoo B.K., Choi H.G., Woo J.S., Yong CS.-Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.-Int. J. Pharm., 377(1-2), 1-8, 2009.
60. Uchegbu I.F., Florence A.T.-Non-ionic surfactant vesicles (niosomes) physical and pharmaceutical chemistry.-Adv. Colloid Interface Sci., 58,1-55,1995.